Table 2 The characteristics of patients with anti-HCV positive
Total (n = 93) | Patients with HCV RNA positive (n = 59) | Patients with HCV RNA negative (n = 34) | P | |
|---|---|---|---|---|
Age (year) | 54.0 (44.8–62.6) | 56.3 (47.5–63.6) | 53.2 (43.0–59.9) | 0.153 |
Sex | 0.634 | |||
Male | 63 (67.7) | 41 (69.5) | 22 (64.7) | |
Female | 30 (32.3) | 18 (30.5) | 12 (35.5) | |
BMI (kg/m2) | 22.1 (19.3–24.5) | 21.8 (18.5–23.8) | 22.5 (19.8–25.8) | 0.307 |
IDU | 15 (16.1) | 11(18.6) | 4 (11.8) | 0.560 |
MSM | 2(2.2) | 1(1.7) | 1 (2.9) | 1.000 |
Dialysis vintage | 7.0 (4.0–13.0) | 7.0 (5.0–13.0) | 7.5 (3.8–13.0) | 0.575 |
ALT (U/L) | 19.5 (14.0–27.5) | 22 (16–38) | 17 (13–23.5) | 0.072 |
AST (U/L) | 24 (17–32.5) | 26.5 (17.3–36.8) | 20 (14–26.5) | 0.039* |
Cr (mg/dL) | 9.2 (6.9–11.1) | 9.4 (6.7–11.1) | 8.7 (7.3–11.3) | 0.597 |
APRI | 0.29 (0.20–0.42) | 0.31 (0.22–0.61) | 0.26 (0.18–0.33) | 0.122 |